Effects of arginine-vasopressin and parathyroid hormone-related protein (1-34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis

Osteoarthritis and Cartilage

Volumn 14, Issue 7, 2006, Pages 652-659

  Petersson, M ^a   Bucht, E ^a   Granberg, B ^b   Stark, A ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arginine vasopressin; cAMP; Cell proliferation; Human chondrocytes; Osteoarthritis; Parathyroid hormone related protein; Rheumatoid arthritis; YKL 40

Indexed keywords

ARGIPRESSIN; CYCLIC AMP; GLYCOPROTEIN; PARATHYROID HORMONE RELATED PROTEIN; THYMIDINE;

ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS;

ARGININE VASOPRESSIN; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CELL PROLIFERATION; CHONDROCYTES; GLYCOPROTEINS; HUMANS; LECTINS; OSTEOARTHRITIS; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 33744917275     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.01.003     Document Type: Article

References (49)

1. Chowdrey H.S., Lightman S.L., Harbuz M.S., Larsen P.J., and Jessop D.S. Contents of corticotropin releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during chronic inflammatory stress. J Neuroimmunol 53 (1994) 17-21
2. Zingg H.H. Vasopressin and oxytocin receptors. Baillières Clin Endocrinol Metab 10 (1996) 75-96
3. Chikanza I.C., Petrou P., and Chrousos G. Perturbations of arginine-vasopressin secretion during inflammatory stress: pathophysiologic implications. Ann N Y Acad Sci 917 (2000) 825-834
4. Liu J.H., Muse K., Contreras P., Gibbs D., Vale W., Rivier J., et al. Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. J Clin Endocrinol Metab 57 (1983) 1087-1089
5. Chikanza I.C., and Grossman A.S. Hypothalamic-pituitary mediated immunomodulation: arginine vasopressin is a neuroendocrine immune mediator. Br J Rheumatol 37 (1998) 131-136
6. Croiset G., Heijnen C.J., and DeWied D. Passive avoidance behaviour, vasopressin and the immune system. A link between avoidance latency and immune response. Neuroendocrinology 51 (1990) 156-161
7. Torres B.A., and Johnson H.M. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes. J Immunol 140 7 (1988) 2179-2183
8. 3H-methyl]thymidine incorporation and replication of rat chondrocytes grown in tissue culture by plasma, tissue extracts and vasopressin. Endocrinology 100 (1977) 1365-1375
9. Lagumdzija A., Bucht E., Stark A., Hulting A.-L., and Petersson M. Arg-vasopressin increases proliferation of human osteoblast-like cells and decreases production of interleukin-6 and macrophage colony-stimulating factor. Regul Pept 121 (2004) 41-48
10. Moseley J.H., Kubota M., Diefenbach-Jagger H., Wettenhall R.E., Kemp B.E., Suva L.J., et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A 84 (1987) 5048-5052
11. Stewart A.F., Wu T., Goumas D., Burtis W.J., and Broadus A.E. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun 146 (1987) 672-678
12. Strewler G.J., Stern P.H., Jacobs J.W., Eveloff J., Klein R.F., Leung S.C., et al. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80 (1987) 1803-1807
13. Strewler G.J. The physiology of parathyroid hormone-related protein. N Engl J Med 342 (2000) 177-185
14. Yamamoto S., Morimoto I., Tanaka Y., Yanagihara N., and Eto S. The mutual regulation of arginine-vasopressin and PTHrP secretion in dissociated supraotic neurons. Endocrinology 143 (2002) 1521-1529
15. Karaplis A.C., and Vautour L. Parathyroid hormone-related peptide and parathyroid hormone/parathyroid hormone-related peptide receptor in skeletal development. Curr Opin Nephrol Hypertens 6 (1997) 308-313
16. Karaplis A.C., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L., Kronenberg H.M., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8 (1994) 277-289
17. Kohno H., Shigeno C., Kasai R., Akiyama H., Iida H., Tsuboyama T., et al. Synovial fluids from patients with osteoarthritis and rheumatoid arthritis contain high levels of parathyroid hormone-related peptide. J Bone Miner Res 12 5 (1997) 847-854
18. Okano K., Tsukazaki T., Ohtsuru A., Osaki M., Yonekura A., Iwasaki K., et al. Expression of parathyroid hormone-related peptide in human osteoarthritis. J Orthop Res 15 2 (1997) 175-180
19. Benz K., Breit S., Lukoschek M., Mau H., and Richter W. Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem Biophys Res Commun 293 (2002) 284-292
20. Imabayashi H., Mori T., Gojo S., Kiyono T., Sugiyama T., Irie R., et al. Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by largescale cDNA analysis. Exp Cell Res 288 (2003) 35-50
21. Stokes D.G., Liu G., Coimbra I.B., Piera-Velazquez S., Crowl R.M., and Jimenez S.A. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46 (2002) 404-419
22. Johansen J.S., Kirwan J.R., Price P.A., and Sharif M. Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. Scand J Rheumatol 30 (2001) 297-304
23. Johansen J.S., Hvolris J., Hansen M., Backer V., Lorenzen I., and Price P.A. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 35 (1996) 553-559
24. Johansen J.S., Stoltenberg M., Hansen M., Florescu A., Horslev-Petersen K., Lorentzen I., et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology (Oxford) 38 (1999) 618-626
25. Johansen J.S., Olee T., Price P.A., Hashimoto S., Ochs R.L., and Lotz M. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum 44 (2001) 826-837
26. Hakala B.E., White C., and Recklies A.D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268 (1993) 25803-25810
27. Matsumoto T., and Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin Exp Rheumatol 19 (2001) 655-660
28. Volck B., Johansen J.S., Stoltenberg M., Garbarsch C., Price P.A., Ostergaard M., et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 9 (2001) 203-214
29. Elands J., Resink A., and De Kloet E.R. Neurohypophyseal hormone receptors in the rat thymus, spleen and lymphocytes. Endocrinology 126 (1990) 2703-2710
30. Funk J.L. A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases. Int Immunopharmacol 1 (2001) 1101-1121
31. Patchev V.K., Mastorakos G., Brady L.S., Redwine J., Wilder R.L., and Chrousos G.P. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 58 (1993) 106-110
32. Ehymayed H.M., and Jansky L. A discrete model of the anti-pyretic actions of AVP, MSH and ACTH. Physiol Res 41 (1992) 57-61
33. Spangelo B.L., deHoll P.D., Kalabay L., Bond B.R., and Arnaud P. Neurointermediate pituitary lobe cells synthesize and release interleukin-6 in vitro: effects of lipopolysaccharide and interleukin-1 beta. Endocrinology 135 (1994) 556-563
34. Hu S.B., Zhao Z.S., Yhap C., Grinberg A., Huang S.P., Westphal H., et al. Vasopressin receptor 1a-mediated negative regulation of B cell receptor signaling. J Neuroimmunol 135 (2003) 72-81
35. Adachi N., Yamaguchi K., Miyake Y., Honda S., Nagasaki K., Akiyama Y., et al. Parathyroid hormone-related protein is a possible autocrine growth inhibitor for lymphocytes. Biochem Biophys Res Commun 166 (1990) 1088-1094
36. Jefferies W.M. Cortisol and immunity. Med Hypotheses 34 (1991) 198-208
37. Bucht E., Eklund A., Toss G., Lewensohn R., Granberg B., Sjöstedt U., et al. Parathyroid hormone-related peptide, measured by a midmolecule radioimmunoassay, in various hypercalcaemic and normocalcaemic conditions. Acta Endocrinol 127 (1992) 294-300
38. Bucht E., Rong H., Pernow Y., Nordqvist A.C., Eriksson E., Rankin W., et al. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia. Cancer Res 58 (1998) 4113-4116
39. Funk J.L., Chen J., Downey K.J., Davee S.M., and Stafford G. Blockade of parathyroid hormone-related protein prevents joint destruction and granuloma formation in streptococcal cell wall-induced arthritis. Arthritis Rheum 48 6 (2003) 1721-1731
40. Funk J.L., Cordaro L.A., Wei H., Benjamin J.B., and Yocum D.E. Synovium as a source of increased PTHrP expression in rheumatoid arthritis. J Clin Invest 101 (1998) 1362-1371
41. Tsai J.A., Rong H., Törring O., Matsushita H., and Bucht E. Interleukin-1β upregulates PTHrP mRNA expression and protein production and decreases TGF-β in normal human osteoblast-like cells. Calcif Tissue Int 66 (2000) 363-369
42. Volck B., Ostergaard K., Johansen J.S., Garbarsch C., and Price P.A. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. Scand J Rheumatol 28 (1999) 171-179
43. Knorr T., Obermayr F., Bartnik E., Zien A., and Aigner T. YKL-39 (chitinase 3-like protein 2) but not YKL-40 (chitinase 3-like protein 1) is upregulated in osteoarthritic chondrocytes. Ann Rheum Dis 62 (2003) 995-998
44. Steck E., Breit S., Breusch S.J., Axt M., and Richter W. Enhanced expression of the human chitinase 3-like protein 2 gene (YKL-39) but not chitinase 3-like protein 1 gene (YKL-40) in osteoarthritic cartilage. Biochem Biophys Res Commun 299 (2002) 109-115
45. De Ceuninck F., Gaufillier S., Bonnaud A., Sabatini M., Lesur C., and Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285 (2001) 926-931
46. Recklies A.D., White C., and Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signaling pathways. Biochem J 365 (2002) 119-126
47. Ling H., and Recklies A.D. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J 380 (2004) 651-659
48. Kenefick R.W., Hazzard M.P., Mahood N.V., and Castellani J.W. Thirst sensations and AVP responses at rest and during exercise cold exposure. Med Sci Sports Exerc 36 (2004) 1528-1534
49. Khamnei S., Hosseinlou A., and Ibrahimi H. The effect of volume on consumed water on drinking induced sweating and plasma levels of arginine vasopressin, epinephrine and norepinephrine. Int J Endocrinol Metab 2 (2004) 19-28